SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-217396
Filing Date
2019-08-09
Accepted
2019-08-09 06:45:26
Documents
5
Effectiveness Date
2019-08-09

Document Format Files

Seq Description Document Type Size
1 S-8 d789108ds8.htm S-8 84159
2 EX-5.1 d789108dex51.htm EX-5.1 8142
3 EX-23.1 d789108dex231.htm EX-23.1 1443
4 EX-23.2 d789108dex232.htm EX-23.2 1535
5 GRAPHIC g789108g21c22.jpg GRAPHIC 4355
  Complete submission text file 0001193125-19-217396.txt   102556
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233162 | Film No.: 191011268
SIC: 2836 Biological Products, (No Diagnostic Substances)